# Anhui BBCA Pharmaceuticals

Anhui BBCA Pharmaceuticals is a Corporate Investor based in Hefei, China.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Hefei, China
- **Region:** Asia
- **Address:** No. 16 Dalian Road, Baohe Industrial Park, Hefei, Anhui, China
- **Founded:** 2008
- **Assets under management:** Undisclosed
- **Website:** http://www.bbcayy.com
- **LinkedIn:** https://www.linkedin.com/company/anhui-bbca-pharmaceutical-co-ltd

## Regulatory record

- **Reports private funds:** No

## About

BBCA Pharmaceuticals is constituted of three systems which are pharmaceutical R&amp;D, production, and sale. It has 5 pharmaceutical plants and 45 GMP certified production line, mainly involving R&amp;D, production and sale of biological pharmacy, chemical pharmacy, and traditional Chinese medicine,and possessing nine classes of products including antipyretic-analgesic drug, cardiovascular drug, antibiotic, nervous system drug,anti-tumor drug, antiulcer drug, hormones drug, nutriceutical,and preparation of traditional Chinese medicine,etc. BBCA Pharmaceuticals can produce 11 kinds of dosage form, including large-volume injection, small-volume injection, powder injection, capsules, powders, tablets, granules, films, eye drops, patches, etc, 395 varieties, as well as many kinds of material drugs.

## Sectors

- Pharmaceuticals
- Healthcare Services

## Offices

- No. 6288 Donghai Road, High-tech Development Zone, Bengbu, Anhui, China
- No. 16 Weisi Road, Baohe Industrial Park, Hefei, Anhui, China

## People

- Li Rongjie — President and Founder, BBCA Group (Fengyuan Group)
- Lian Baohua — Former Deputy GM, Anhui BBCA Pharmaceuticals; Secretary to the Board, Huishang Bank

## Questions

### Who runs investment decisions at Anhui BBCA Pharmaceuticals?

Li Rongjie, the founder and president of BBCA Group (Fengyuan Group), sits at the top of the decision-making structure. The firm does not operate with an external investment committee; decisions flow through the group's senior leadership. As a corporate investor, the investment process is integrated with the parent company's strategic planning rather than run by a dedicated fund manager.

### How is Anhui BBCA Pharmaceuticals related to BBCA Group and BBCA Biochemical?

Anhui BBCA Pharmaceuticals functions as a corporate investment vehicle under Anhui BBCA Group, also known as Fengyuan Group. BBCA Biochemical, a sister entity, manufactures biochemical products such as citric acid and amino acids. In 2012, COFCO Corporation acquired a controlling stake in BBCA Biochemical from the group (per corporate filings, 2012), but BBCA Pharmaceuticals remained under the original parent structure.

### Does Anhui BBCA Pharmaceuticals invest as a financial LP in external funds?

The firm operates as a corporate investor deploying its own balance sheet, not as a limited partner in third-party funds. Its investment activity serves the parent group's industrial strategy — primarily direct investments in pharmaceutical manufacturing, technology, and infrastructure that align with existing production capacity.

### What role does the firm's participation in the China Association of Development Strategy play?

Senior management participates in the association's Bio-pharmaceutical Development Strategy Committee, which provides direct exposure to industry policy discussions and regulatory developments. This connection is standard operating structure for major Chinese pharmaceutical conglomerates navigating a sector where state policy heavily shapes market access, pricing, and manufacturing standards.

### How does the Hefei and Bengbu dual-location footprint affect the firm's investment posture?

The firm maintains a headquarters and R&D center in Hefei's Baohe Industrial Park while manufacturing operations sit in Bengbu. This split maps directly onto the firm's investment priorities: Hefei supports technology scouting and corporate development, while Bengbu represents the production base that investment activity seeks to expand or strengthen through capacity-driven capital deployment.

## Related profiles

- [Angus Moore Wealth Management](https://altss.com/profile/angus-moore-wealth-management)
- [Anhui Deli Household Glass](https://altss.com/profile/anhui-deli-housedhold-glass)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/anhui-bbca-pharmaceuticals

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology
